Marketing-authorisation holder
Orphan Europe SARL
9 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Carbaglu 200 mg, dispergeerbare tablettenDispergeerbare tablet | Carglumic acid | Netherlands | Authorised | 2003 |
| Cystadane 1 g/g, poeder voor oraal gebruikPoeder voor oraal gebruik | Betaine | Netherlands | Authorised | 2007 |
| Cystadrops 3,8 mg/ml oogdruppels, oplossingOogdruppels, oplossing | Mercaptamine | Netherlands | Authorised | 2016 |
| Cystagon, capsules 150 mgCapsule, hard | Mercaptamine, Siliciumdioxide | Netherlands | Authorised | 1997 |
| Cystagon, capsules 50 mgCapsule, hard | Mercaptamine | Netherlands | Authorised | 1997 |
| Pedea 5 mg/ml, oplossing voor injectieOplossing voor injectie | Ibuprofen | Netherlands | Authorised | 2004 |
| Vedrop 50mg/ml, drankDrank | Vitamin e, Tocofersolan | Netherlands | Authorised | 2009 |
| Wilzin 25 mg, harde capsulesCapsule, hard | Zinc | Netherlands | Authorised | 2004 |
| Wilzin 50 mg, harde capsulesCapsule, hard | Zinc | Netherlands | Authorised | 2004 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 9 | 9 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Other alimentary tract and metabolism productsAlimentary tract and metabolism · ATC A16A
- VitaminsAlimentary tract and metabolism · ATC A11H
- Cardiac therapyCardiovascular system · ATC C01E
- OphthalmologicalsSensory organs · ATC S01X
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- orphan europe
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 9
- Countries
- 1
- Roles
- Authorisation holder and manufacturer